The FDA issued a new warning about hydroxychloroquine and chloroquine on April 24, saying the drugs can cause serious and potentially life-threatening heart rhythm problems and should be limited to clinical trials or certain hospitalized patients. That landed directly on top of Trump’s months-long habit of talking up the drug as a possible coronavirus fix. The agency’s warning was a blunt public correction to the president’s messaging. It also underscored how far the White House had drifted from evidence-based pandemic guidance.
First recorded Apr 24, 2020·Meaningfully updated Apr 24, 2020
Returning reader
What changed
FDA Reins In Trump’s Hydroxychloroquine Hype
The FDA issued a new warning about hydroxychloroquine and chloroquine on April 24, saying the drugs can cause serious and potentially life-threatening heart rhythm problems and should be limited to clinical trials or certain hospitalized patients. That landed directly on top of Trump’s months-long habit of talking up the drug as a possible coronavirus fix. The agency’s warning was a blunt public correction to the president’s messaging. It also underscored how far the White House had drifted fro…
The FDA issued a new warning about hydroxychloroquine and chloroquine on April 24, saying the drugs can cause serious and potentially life-threatening heart rhythm problems and should be limited to clinical trials or certain hospitalized patients. That landed directly on top of Trump’s months-long habit of talking up the drug as a possible coronavirus fix. The agency’s warning was a blunt public correction to the pr…
Truth standard
What TDF can prove
The linked reports preserve their sources, audit notes, confidence rating, corrections, and comments. The page Q&A below is restricted to those connected materials and will say when the evidence does not establish an answer.
